I am a thoracic surgeon with expertise in the diagnosis and treatment of cancers in the chest — lung cancer, esophageal cancer, mesothelioma, thymoma, mediastinal and chest wall tumors, and cancers metastatic to lung and pleura.
My clinical interests include systematic workup of lung nodules for early diagnosis of lung cancer, accurate staging of thoracic cancers by endoscopic methods such as endobronchial ultrasound (EBUS), and video-assisted thorascopic surgery (VATS). I take pride in effective communication with patients, family members, and their primary care physicians by constant and direct access. I perform minimally invasive, robotic, and open surgical procedures with a focus on patient-oriented outcomes (cancer control, quality of life).
I am involved in clinical research, and am currently the co-Principal Investigator on two trials at Memorial Sloan Kettering: Protocol 11-037 and Protocol 11-192.
I conduct laboratory research focused on the development of biomarkers (blood tests) for early detection of cancer and gene therapy for thoracic cancers. These therapies include immunotherapy (enhancing patients’ own immune systems using genetic and cell engineering) and oncolytic viral therapy (killing cancer cells using genetically engineered viruses).
This research is supported by the National Cancer Institute, the Department of Defense, the American Association for Cancer Research, the International Association for the Study of Lung Cancer, the National Lung Cancer Partnership, the American Association for Thoracic Surgery, the Mesothelioma Applied Research Foundation, the Esophageal Cancer Education Foundation, the New York State Empire Clinical Research Investigator Program, the Stony Wold-Herbert Fund, and Memorial Sloan Kettering’s Experimental Therapeutics Center, as well as several other foundations.
I mentor surgical trainees, research fellows, and bioengineering students (from the City College of New York). The strength of their training is reflected in their multiple presentations at international conferences and peer-reviewed publications.
- Clinical Expertise: Lung Cancer, Esophageal Cancer, Mediastinal and Chest Wall Tumors, Mesothelioma, Thymoma, Cancers Metastatic to Lung and Pleura, Carcinoid; Video-assisted Thoracic Surgery (VATS), Minimally-invasive and Robotic-assisted Surgery, Laparoscopy, Lobectomy, Bronchoscopy, Endobronchial Ultrasound (EBUS), Laser Surgery, Gastrointestinal Endoscopy, Tracheal and Esophageal Stents, PleurX catheter placement
- Languages Spoken: English
- Education: MD, Guntur Medical College (India)
- Residencies: All India Institute of Medical Sciences (New Delhi, India); Southampton University Hospitals (UK); Maimonides Medical Center; Lenox Hill Hospital
- Fellowships: Memorial Sloan Kettering Cancer Center; University of Pittsburgh
- Board Certifications: Thoracic Surgery; General Surgery
Selected Books and Book Chapters
“Non-surgical staging of esophageal carcinoma.” Adusumilli PS, Patel AN. In: The SAGES Manual of Strategic Decision Making: Case Studies in Minimal Access Surgery. Scott-Conner C, ed. New York: Springer; 2008.
Kaplan USMLE Step3 Qbook. 3rd ed. Levy E, Manley MS, Manley LD, Anschel DJ, Adusumilli PS. New York: Kaplan Medical; 2006.
Brain death and organ transplantation in India. 2nd ed. Peush S, Pande V, Prasad AS, Reddy KS, Nundy S, eds. New Delhi: Oxford UP; 1999.
Research is integral to our mission at Memorial Sloan Kettering, and clinical trials help us discover better forms of patient care and treatment. For you, this could mean access to a new therapy or therapy combination. Click to see a list of the trials I’m currently leading.
Clinical Trials Led by Prasad S. Adusumilli
- A Phase I Study of Immunotherapy with Genetically Engineered T Cells (CAR T Cells) for Advanced Breast Cancer
- A Phase I Study of Immunotherapy with Genetically Engineered T Cells (CAR T Cells) to Treat Mesothelioma and Malignant Pleural Disease from Lung and Breast Cancers
- A Prospective Clinical Trial to Evaluate Mesothelin as a Biomarker for the Clinical Management of Esophageal Cancer
Clinical Trials Co-Investigated by Prasad S. Adusumilli
Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.Learn more